Global Clinical Chemistry Market Analyzed & Forecast in New Study Published at MarketPublishers.com
09 Jul 2012 • by Natalie Aster
LONDON – The global clinical chemistry market was valued at over USD 9 billion in 2011, and it is likely to grow moderately through 2015. Toxicology, hemoglobin and cholesterol testing segments, which contributed more than 40% of market revenues last year, are likely to dominate the market up to 2015. Faecal occult blood testing market, cardiac enzyme testing market and prothrombin time/international normalized ratio (PT/INR) testing market are expected to grow with double digit CAGRs from 2012 to 2015.
Last year, the United States and Europe together held over 85% market share. But China is expected to nearly double its market revenue from 2011, thus reducing the market share of Europe in the worldwide clinical chemistry market by 2015.
New market study “Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis” drawn up by Renub Research provides a comprehensive assessment of the nine clinical chemistry tests market & reviews, analyzes and projects clinical chemistry market from a global perspective and in seven key countries – the US, Europe, China, Brazil, India, Mexico, Taiwan. The study also provides market landscape and market share information in the clinical chemistry market. Furthermore, key drivers and challenges of the worldwide clinical chemistry market are also discussed in detail.
Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis
Published: July, 2012
Price: US$ 1.275,00
More new market studies by the publisher can be found at Renub Research page.